{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:14:03Z","timestamp":1794978843151,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Multidrug-resistant tuberculosis (MDR-TB) has become a major global public health issue, which has worsened over time owing to changes in disease-related trends. This study aimed to determine global trends in MDR-TB among children and adolescents for strategic health planning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A secondary analysis was performed on MDR-TB burden among children and adolescents (&lt;20 years) at the global, regional, and national levels based on sociodemographic index (SDI) quintiles from 1990 to 2019, using the Global Burden of Disease (GBD) 2019 database.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 2019, 67,710.82 (95% uncertainty interval [UI]: 38,823.61 to 110,582.03) incidents of MDR-TB were reported among children and adolescents aged &lt;20 years worldwide. The global incidence rate has increased from 1990 to 2019, with the estimated annual percentage change (EAPC) at 4.15% (95% UI: 1.10\u201312.19%), particularly in low- and low-middle SDI regions. The top three highest incidence rates were observed in Southern sub-Saharan Africa, Eastern Europe, and South Asia. The mortality and disability-adjusted life years (DALYs) rates (0.62 [95% UI: 0.28\u20131.14] and 55.19 [95% UI: 25.24\u2013100.74] cases per 100,000, respectively) were higher among children aged &lt;5 years than those in older age groups in 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The global burden of MDR-TB among children and adolescents has increased from 1990 to 2019, particularly in regions with lower SDI. Extensive collaborative research and interventions are needed to mitigate this disease burden to secure the health of our future generation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Impact<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>MDR-TB disease burden in children and adolescents using GBD 2019 database was analyzed.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>In total, 67710.82 MDR-TB cases were identified in children and adolescents in 2019.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Global MDR-TB burden in children and adolescents has risen over the past 30 years.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>MDR-TB disease burden is negatively correlated with the sociodemographic index.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>MDR-TB disease burden varies across countries and age groups.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41390-025-03917-1","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:24:53Z","timestamp":1739276693000},"page":"901-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global burden of multidrug-resistant tuberculosis in children and adolescents"],"prefix":"10.1038","volume":"98","author":[{"given":"Yanyan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"3917_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S1473-3099(17)30246-3","volume":"17","author":"A Mariandyshev","year":"2017","unstructured":"Mariandyshev, A. & Eliseev, P. Drug-resistant tuberculosis threatens WHO\u2019s end-Tb strategy. Lancet Infect. Dis. 17, 674\u2013675 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"3917_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/resp.13143","volume":"23","author":"K Dheda","year":"2018","unstructured":"Dheda, K. et al. Recent controversies about MDR and XDR-Tb: global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology 23, 36\u201345 (2018).","journal-title":"Respirology"},{"key":"3917_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","volume":"77","author":"IS Pradipta","year":"2018","unstructured":"Pradipta, I. S., Forsman, L. D., Bruchfeld, J., Hak, E. & Alffenaar, J. W. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J. Infect. 77, 469\u2013478 (2018).","journal-title":"J. Infect."},{"key":"3917_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange, C. et al. Management of drug-resistant tuberculosis. Lancet 394, 953\u2013966 (2019).","journal-title":"Lancet"},{"key":"3917_CR5","unstructured":"World Health Organization. Drug-Resistant Tb: Surveillance and Response: Supplement to Global Tuberculosis Report 2014, https:\/\/www.Who.Int\/Publications\/I\/Item\/Who-Hq-Tb-2014.12,World Healthorganization, Accessed October 31, 2023."},{"key":"3917_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2471\/BLT.11.092585","volume":"90","author":"M Zignol","year":"2012","unstructured":"Zignol, M. et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007\u20132010. Bull. World Health Organ. 90, 111\u2013119d (2012).","journal-title":"Bull. World Health Organ."},{"key":"3917_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2147\/IDR.S453306","volume":"17","author":"H Mezgebe","year":"2024","unstructured":"Mezgebe, H. et al. Prevalence of smear-positive, rifampicin-resistant Mycobacterium tuberculosis and related factors among residents with cough in Northern Ethiopian Refugee Health facilities. Infect. Drug Resist. 17, 1135\u20131145 (2024).","journal-title":"Infect. Drug Resist."},{"key":"3917_CR8","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar, M. et al. WHO\u2019s New End Tb Strategy. Lancet 385, 1799\u20131801 (2015).","journal-title":"Lancet"},{"key":"3917_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.micpath.2018.02.047","volume":"117","author":"M Saravanan","year":"2018","unstructured":"Saravanan, M. et al. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia. Microb. Pathog. 117, 237\u2013242 (2018).","journal-title":"Microb. Pathog."},{"key":"3917_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02023-1","volume":"11","author":"S Harichander","year":"2022","unstructured":"Harichander, S., Wiafe, E., Mensah, K. B., Bangalee, V. & Oosthuizen, F. The incidence of Tb and Mdr-Tb in pediatrics and therapeutic options: a systematic review. Syst. Rev. 11, 157 (2022).","journal-title":"Syst. Rev."},{"key":"3917_CR11","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","volume":"3","author":"GBD2015HIVCollaborators.","year":"2016","unstructured":"GBD2015HIVCollaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the global burden of disease study 2015. Lancet HIV 3, e361\u2013e387 (2016).","journal-title":"Lancet HIV"},{"key":"3917_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","volume":"18","author":"GBDTuberculosisCollaborators.","year":"2018","unstructured":"GBDTuberculosisCollaborators. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect. Dis. 18, 261\u2013284 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"3917_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-021-00803-w","volume":"10","author":"ZJ Ou","year":"2021","unstructured":"Ou, Z. J. et al. Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the global burden of disease study. Infect. Dis. Poverty 10, 24 (2021).","journal-title":"Infect. Dis. Poverty"},{"key":"3917_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470\u2013480 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"3917_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1183\/09031936.00175812","volume":"42","author":"M Zignol","year":"2013","unstructured":"Zignol, M. et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur. Respir. J. 42, 701\u2013707 (2013).","journal-title":"Eur. Respir. J."},{"key":"3917_CR16","doi-asserted-by":"publisher","first-page":"e0268560","DOI":"10.1371\/journal.pone.0268560","volume":"17","author":"DT Wademan","year":"2022","unstructured":"Wademan, D. T. et al. Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children. PLoS One 17, e0268560 (2022).","journal-title":"PLoS One"},{"key":"3917_CR17","unstructured":"WorldHealthOrganization (World Health Organization 2022)."},{"key":"3917_CR18","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1016\/S2214-109X(22)00113-9","volume":"10","author":"PJ Dodd","year":"2022","unstructured":"Dodd, P. J., Mafirakureva, N., Seddon, J. A. & McQuaid, C. F. The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study. Lancet Glob. Health 10, e1034\u2013e1044 (2022).","journal-title":"Lancet Glob. Health"},{"key":"3917_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185646","volume":"12","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Esmpe: a combined strategy for school tuberculosis prevention and control proposed by Dalian, China. PLoS One 12, e0185646 (2017).","journal-title":"PLoS One"},{"key":"3917_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.puhe.2018.02.004","volume":"158","author":"CL Walker","year":"2018","unstructured":"Walker, C. L., Duffield, K., Kaur, H., Dedicoat, M. & Gajraj, R. Acceptability of latent tuberculosis testing of migrants in a college environment in England. Public Health 158, 55\u201360 (2018).","journal-title":"Public Health"},{"key":"3917_CR21","doi-asserted-by":"publisher","first-page":"e0133477","DOI":"10.1371\/journal.pone.0133477","volume":"10","author":"EG Miftode","year":"2015","unstructured":"Miftode, E. G. et al. Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis. PLoS One 10, e0133477 (2015).","journal-title":"PLoS One"},{"key":"3917_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMra1008049","volume":"367","author":"CM Perez-Velez","year":"2012","unstructured":"Perez-Velez, C. M. & Marais, B. J. Tuberculosis in children. N. Engl. J. Med. 367, 348\u2013361 (2012).","journal-title":"N. Engl. J. Med."},{"key":"3917_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijid.2020.03.064","volume":"96","author":"HH Tola","year":"2020","unstructured":"Tola, H. H., Khadoura, K. J., Jimma, W., Nedjat, S. & Majdzadeh, R. Multidrug resistant tuberculosis treatment outcome in children in developing and developed countries: a systematic review and meta-analysis. Int J. Infect. Dis. 96, 12\u201318 (2020).","journal-title":"Int J. Infect. Dis."},{"key":"3917_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/cid\/ciw489","volume":"63","author":"SS Chiang","year":"2016","unstructured":"Chiang, S. S. et al. Baseline predictors of treatment outcomes in children with multidrug-resistant tuberculosis: a retrospective cohort study. Clin. Infect. Dis. 63, 1063\u20131071 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"3917_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.5588\/ijtld.14.0231","volume":"18","author":"RM Hicks","year":"2014","unstructured":"Hicks, R. M. et al. Malnutrition associated with unfavorable outcome and death among South African MDR-Tb and HIV co-infected children. Int. J. Tuberc. Lung Dis. 18, 1074\u20131083 (2014).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"3917_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.5588\/ijtld.15.0178","volume":"19","author":"SS Chiang","year":"2015","unstructured":"Chiang, S. S. et al. Barriers to the diagnosis of childhood tuberculosis: a qualitative study. Int. J. Tuberc. Lung Dis. 19, 1144\u20131152 (2015).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"3917_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5588\/ijtld.21.0488","volume":"26","author":"I Darnton-Hill","year":"2022","unstructured":"Darnton-Hill, I., Mandal, P. P., de Silva, A., Bhatia, V. & Sharma, M. Opportunities to prevent and manage undernutrition to amplify efforts to end Tb. Int. J. Tuberc. Lung Dis. 26, 6\u201311 (2022).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"3917_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5588\/pha.15.0007","volume":"5","author":"P du Cros","year":"2015","unstructured":"du Cros, P. et al. Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in central Asia. Public Health Action 5, 99\u2013102 (2015).","journal-title":"Public Health Action"},{"key":"3917_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05749-2","volume":"21","author":"ZZ Sultana","year":"2021","unstructured":"Sultana, Z. Z. et al. Hiv infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 21, 51 (2021).","journal-title":"BMC Infect. Dis."},{"key":"3917_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5588\/ijtld.17.0412","volume":"22","author":"JR Francis","year":"2018","unstructured":"Francis, J. R. et al. Multidrug-resistant tuberculosis in Australia, 1998-2012. Int. J. Tuberc. Lung Dis. 22, 294\u2013299 (2018).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"3917_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41479-020-00078-z","volume":"12","author":"BA Sayed","year":"2020","unstructured":"Sayed, B. A., Posey, D. L., Maskery, B., Wingate, L. T. & Cetron, M. S. Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas. Pneumonia 12, 15 (2020).","journal-title":"Pneumonia"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03917-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:11:50Z","timestamp":1759911110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03917-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-03917-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilizes data from the Global Burden of Disease (GBD) 2019 database, which is publicly available and de-identified, informed consent were not required for this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}